patient_id,note_date,index_date,eligible_label,ineligible_reasons,age,sex,race_ethnicity,height_cm,weight_kg,bmi,smoking_status,alcohol_use,outpatient_visits_last_12m,diagnoses,medications,allergies,pregnancy_status,recent_cardiovascular_event_6m,systemic_steroids_chronic,active_malignancy_systemic_tx_12m,narrative_note
P0001,2025-11-06,2025-11-09,ELIGIBLE,,41,Female,Black or African American,172,88,29.7,Current,None,6,Type 2 diabetes mellitus; Hypertension,Metformin 1000 mg BID; Empagliflozin 10 mg daily; Rosuvastatin 10 mg daily,NKDA,N/A,No,No,No,"41-year-old Female with a history of type 2 diabetes diagnosed 2 years ago. Seen for routine outpatient follow-up. Reports occasional nocturia. Current therapy: Metformin 1000 mg BID; Empagliflozin 10 mg daily; Rosuvastatin 10 mg daily. Home glucose readings: fasting 130â€“170 mg/dL. Comorbidities: hypertension. Denies hypoglycemia requiring assistance. Last HbA1c on 2025-11-09 was 9.0%. Plan: continue current regimen, reinforce diet/exercise, repeat A1c in 3 months."
